Gupta, A., Love, S., Schuh, A., Shanyinde, M., Larkin, J., Plummer, R., . . . Middleton, M. (2014). DOC-MEK: A double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma. Oxford University Press.
Chicago Style (17th ed.) CitationGupta, A., et al. DOC-MEK: A Double-blind Randomized Phase II Trial of Docetaxel with or Without Selumetinib in Wild-type BRAF Advanced Melanoma. Oxford University Press, 2014.
MLA引文Gupta, A., et al. DOC-MEK: A Double-blind Randomized Phase II Trial of Docetaxel with or Without Selumetinib in Wild-type BRAF Advanced Melanoma. Oxford University Press, 2014.
警告:這些引文格式不一定是100%准確.